SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6.18 |
| Enterprise Value ($M) | 10.57 |
| Book Value ($M) | 3.72 |
| Book Value / Share | 0.03 |
| Price / Book | 1.66 |
| NCAV ($M) | -7.39 |
| NCAV / Share | -0.07 |
| Price / NCAV | -0.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.26 |
| Return on Assets (ROA) | -1.31 |
| Return on Equity (ROE) | -4.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.55 |
| Current Ratio | 0.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 11.69 |
| Assets | 22.80 |
| Liabilities | 19.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Grant Stuart M. | 3.96 | -27.70 | |
| 13G/A | Armistice Capital, Llc | 9.95 | 96.44 | |
| 13D/A | Ianchulev Tsontcho | 3.20 | -7.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,824,324 | 8,733,135 | 20.89 | |
| 1,532,057 | 11,260,229 | 13.61 | |
| 4,306,269 | 12,161,877 | 35.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ERNA – Eterna Therapeutics Inc. | ESLA – Estrella Immunopharma, Inc. |
| EVOK – Evoke Pharma, Inc. | FBIO – Fortress Biotech, Inc. |
| FBRX – Forte Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io